# Enhanced reverse zoonotic potential and immune evasion by omicron JN.1 variant

**Authors:** Jiaxin Hu, Fuwen Zan, Yixin He, Xiuyuan Ou, Xiaolu Tang, Yan Liu, Xing Lu, Pei Li, Zhixia Mu, Siwen Dong, Yahan Chen, Lin Tan, Mengmeng Cao, Pinghuang Liu, Terrence Tsz-Tai Yuen, Jian Lu, Zhaohui Qian

PMC · DOI: 10.1016/j.isci.2025.112824 · iScience · 2025-06-06

## TL;DR

The JN.1 variant of SARS-CoV-2 has a higher risk of spreading to animals and evades the immune system more effectively due to a specific mutation.

## Contribution

This study identifies the L455S mutation as a key driver of increased infectivity and immune evasion in the JN.1 variant.

## Key findings

- JN.1 shows higher reverse zoonotic potential compared to other variants like BA.2.86.
- The L455S mutation increases fusogenicity and infectivity by lowering S protein thermostability.
- XBB breakthrough infection boosts neutralization antibodies against JN.1.

## Abstract

SARS-CoV-2 infects not only humans but also animals, posing reverse zoonotic risks. As SARS-CoV-2 rapidly evolves, JN.1 has become dominant globally. In this study, we determined the susceptibility of XBB.1.16, EG.5.1, BA.2.86, and JN.1 to 27 different animal angiotensin-converting enzyme 2 (ACE2) orthologs using pseudoviruses, and found that JN.1 displayed substantially higher overall reverse zoonotic risk potential compared to other variants except for EG.5.1. Live virus infection experiments further confirmed higher infectivity of JN.1 than BA.2.86. Mechanistic analyses revealed that L455S might be responsible for substantial increase in overall fusogenecity and infectivity by lowering S protein thermostability. Additionally, we also found that L455S mutation enhanced immune evasion of SARS-CoV-2, and XBB breakthrough infection increased levels of neutralization antibodies against JN.1. Together, our findings offer a better mechanistic understanding of CoV entry, host range, evolution, and immunogenicity and highlight the importance of surveillance of susceptible hosts to prevent potential outbreaks.

•JN.1 exhibits a higher potential for reverse zoonotic transmission risk compared to BA.2.86•The L455S mutation decreases receptor binding while increasing fusogenicity and infectivity•Mechanistically, the L455S mutation enhances viral infectivity by reducing S protein stability•Breakthrough infection with XBB strengthens protection against JN.1 infection

JN.1 exhibits a higher potential for reverse zoonotic transmission risk compared to BA.2.86

The L455S mutation decreases receptor binding while increasing fusogenicity and infectivity

Mechanistically, the L455S mutation enhances viral infectivity by reducing S protein stability

Breakthrough infection with XBB strengthens protection against JN.1 infection

Immunology; Virology

## Linked entities

- **Proteins:** ACE2 (angiotensin converting enzyme 2), LOC102617969 (S-protein homolog 24-like)
- **Diseases:** SARS-CoV-2 (MONDO:0100096)

## Full-text entities

- **Genes:** ACE2 (angiotensin converting enzyme 2) [NCBI Gene 59272] {aka ACEH}, S (surface glycoprotein) [NCBI Gene 43740568] {aka spike glycoprotein}
- **Diseases:** infection (MESH:D007239)
- **Species:** Coronaviridae (family) [taxon 11118], Severe acute respiratory syndrome coronavirus 2 (no rank) [taxon 2697049], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** L455S
- **Cell lines:** JN.1 — Homo sapiens (Human), Lung small cell carcinoma, Cancer cell line (CVCL_0C15)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12209934/full.md

## Figures

10 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12209934/full.md

## References

75 references — full list in the complete paper: https://tomesphere.com/paper/PMC12209934/full.md

---
Source: https://tomesphere.com/paper/PMC12209934